Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

The data on the trending tickers is compiled from a list of most-discussed tickers on Benzinga Pro, and the popular Reddit forum WallStreetBets.

SPDR S&P 500 SPY: The market closed on imbalance on Wednesday, with $279 million on the sell-side, and $1.6 billion on the buy-side as the Fed pointed to a reduction in bond holdings at a maximum of $95 billion per month as the central bank raises interest rates. 

Tesla Inc TSLA plans to kick off the Texas Giga factory today with a "Cyber Rodeo" that is expected to attract up to 15,000 people.

Houghton Mifflin Harcourt Co HMHC, a learning technology company, completed its sale to private equity investment firm Veritas Capital in a deal valued at $2.8 billion.

Advent Technologies Holdings Inc ADN shares climbed 79.7% to close at $3.63 on Wednesday. Advent and Hyundai Motor Company entered into a technology assessment, sales, and development agreement.

BigBear.ai Holdings Inc BBAI has moved 28.65% higher in the last five trading sessions on no news as it seems investors have taken interest in BigBear as a momentum play.

Mobiquity Technologies Inc MOBQ surged 29.6% to close at $2.10 after the company announced it has been selected by A-Nation as its data and programmatic advertising provider.

Sunshine Biopharma, Inc. SBFM shares rose 12.1% to close at $6.29. Shares jumped 148% on Tuesday after the company announced two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.

BioXcel Therapeutics Inc BTAI shares are trading 0.35% higher in Thursday's premarket session. On Wednesday, the stock was trading at a volume of 12.6 million shares as of 1:30 p.m; This is 3642.5% of its average full-day volume over the last 100 days.

Tilray Inc TLRY: Analysts at Cantor Fitzgerald maintained a Neutral rating and raised the price target from $6.90 to $8.40 following the company's latest earnings.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapCrowdsourcingTrading IdeasGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...